By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Food and Drug Administration (FDA) 

5600 Fishers Lane

Rockville  Maryland  20857  U.S.A.
Phone: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332) Fax:

FDA Overview:

The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.

•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.

FDA's Mission Statement

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.

Key Statistics

Ownership: Private

Web Site: FDA


Company News
CogState Ltd (CGS.AX) Receives Positive FDA Notification Regarding Medical Device Regulatory Submission 7/27/2017 8:41:40 AM
Aradigm (ARDM) Submits New Drug Application (NDA) To FDA For U.S. Marketing Approval Of Linhaliq In Non-Cystic Fibrosis Bronchiectasis 7/27/2017 8:26:27 AM
Eagle Pharma (EGRX) Receives Complete Response Letter From FDA On RYANODEX For Exertional Heat Stroke Application 7/27/2017 8:11:15 AM
Spectranetics (SPNC) Secures FDA Approval of Stellarex Drug-Coated Balloon 7/27/2017 7:30:52 AM
Capricor (CAPR) Announces Results Of FDA Meeting On Intravenous CAP-1002 For Duchenne Muscular Dystrophy 7/27/2017 7:28:13 AM
Aspect Imaging Nabbed $150 Million and FDA Clearance of the First Dedicated Neonatal MRI System 7/27/2017 7:26:16 AM
U.S. FDA Grants Priority Review For An Epinephrine Auto-Injector In Development By Kaleo Specifically For Infants And Small Children 7/27/2017 7:20:43 AM
AMO Pharma Receives FDA Orphan Drug Designation For AMO-02 For Treatment Of Congenital Myotonic Dystrophy 7/27/2017 6:58:59 AM
Eiger Biopharma Announces FDA Fast Track Designation Granted For Pegylated Interferon Lambda In Hepatitis Delta Virus Infection 7/27/2017 6:37:19 AM
FDA Approves Eisai Inc. (ESALF.PK)'s FYCOMPA (Perampanel) For Use As Monotherapy For The Treatment Of Partial-Onset Seizures 7/27/2017 6:30:27 AM